AB Mauri North America has announced the acquisition of Omega Yeast Labs LLC, effective August 14, 2024. Omega Yeast – a complementary business to AB Mauri's business division, AB Biotek – is a leader in the craft brewing liquid yeast market in the United States.

Omega Yeast's research, development and production headquarters are situated within a state-of-the-art, 14,000-square-foot facility in Chicago. The company is widely touted in the domestic craft brewing segment for its robust innovation capabilities and novel, transformational yeast strains.

“The acquisition of Omega Yeast will further strengthen and accelerate our North American specialty yeast business for craft beer,” says Brent Fenton, president, AB Mauri North America. “This represents a unique opportunity to combine the global technology strength of AB Biotek together with a leading, high-quality liquid yeast producer here in the US.”

Omega Yeast Labs has an extensive portfolio of yeast strains across a wide variety of craft brewing styles, from traditional lagers and ales to West Coast IPAs, hard seltzers and beyond.

“Omega Yeast has supplied professional and home craft brewers across the country with leading liquid yeast solutions for more than the past decade since Lance Shaner and I founded the business in 2013,” says Mark Schwarz, co-founder, Omega Yeast. “We look forward to even greater days ahead under the AB Mauri and AB Biotek umbrella as we expect to grow our footprint in both liquid and dry solutions and build an even more robust portfolio of solutions to meet the needs of craft brewers today and tomorrow.”

The Omega Yeast brand joins AB Mauri’s Fleischmann's Yeast for baking and AB Biotek’s Pinnacle portfolio for beer, wine and distilled spirits as part of a boosted product lineup. AB Mauri has also made recent investments in a specialty dry yeast plant in Hull, United Kingdom, and a beverage applications center in Etten-Leur, The Netherlands.